New Chirplast SRL
1.0 FTENew Chirplast reported total assets of €1.28m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 1 full-time equivalent.
The score of New Chirplast shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +37 % Total assets +15 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
New Chirplast's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 11 Aug 2023
- Year ended 31 Dec 2021filed on 29 Sep 2022
New Chirplast's financial analysis
- Solvency80.3%sector median: 67.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of New Chirplast
New Chirplast's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0478.989.463
- VAT number
- BE0478989463
- Peppol
- Registered · 0208:0478989463 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Dec 2002
- Registered office
- 1081 Koekelberg
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
New Chirplast (SRL) has been based in Koekelberg since 2002, active in: medical specialists activities. For 2025, it reports a net profit of 87,619 € and equity of €1.03m; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 80.3%, above the median of its sector (67.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to New Chirplast
Companies in the same business, of comparable size and area, outside its group.
- EMONTS MICHEL, Cardiologue Medical specialists activities Attert · balance sheet €1.28m
- Dokter Philippe ROSIER Medical specialists activities Edegem · balance sheet €1.29m
- Dr. Jeroen Vanhaecke Medical specialists activities Kortrijk · balance sheet €1.27m
- Declercq MD Medical specialists activities Staden · balance sheet €1.28m
- NAID Medical specialists activities Mouscron · balance sheet €1.28m
- Dr. R. van Bos Medical specialists activities Asse · balance sheet €1.28m
- HELSMOORTEL Aude - Néonatalogie Medical specialists activities Auderghem · balance sheet €1.28m
- Dr. Philip de Smet Medical specialists activities Kontich · balance sheet €1.28m
Frequently asked questions about New Chirplast
What is the revenue of New Chirplast?
New Chirplast files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of New Chirplast?
In Belgium, the VAT number is the company number prefixed with BE: BE0478989463 for New Chirplast, if the company is VAT-registered. Its company number (CBE) is 0478.989.463.
Where is the registered office of New Chirplast?
According to the CBE register, the registered office of New Chirplast is in 1081 Koekelberg.
What is the equity of New Chirplast?
At the close of the 2025 financial year, the equity of New Chirplast amounts to 1,029,283 €, a solvency of 80.3% of total assets.
How many people work at New Chirplast?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages New Chirplast?
The register lists 1 active mandates at New Chirplast. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of New Chirplast
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →